Elevated thyroid stimulating hormone levels are associated with metabolic syndrome in a Chinese community-based population of euthyroid people aged 40 years and older

Abstract

This study investigated whether high-normal thyrotropin (TSH) levels are associated with metabolic syndrome in euthyroid Chinese people≥40 years old. Clinical and metabolic factors were assessed in 2,356 subjects (40–77 years old) with TSH levels in the normal range (0.35–5.00 mU/L). Using 2.50 mU/L as the cut-off point of TSH level within the normal range, we divided subjects into the high-TSH (2.50–5.00 mU/L; n=1,064) and low-TSH (0.35–2.50 mU/L; n=11,292) group. The results showed that the mean levels of body mass index (BMI), total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), and fasting plasma glucose (FPG) were higher in the high-TSH group and TSH levels were significantly positively correlated with BMI, LDL-C, TC, and FPG. The prevalence of central obesity, hypertriglyceridemia, low high density lipoprotein cholesterol (HDL-C), and high FPG (>5.60 mmol/L) was significantly higher in females and subjects with high-TSH levels. Metabolic syndrome was also more prevalent in the high-TSH group. People over the age of 40 years with high-normal TSH levels had an approximately 1.2-fold increased risk of metabolic syndrome, compared with those with low-normal TSH levels, after adjusting for age and gender. In conclusion, high normal TSH is a risk factor for metabolic syndrome in people≥40 years old.

Keywords

thyroid stimulating hormone / euthyroid / metabolic syndrome / central obesity / dyslipidemia

References

[1] Kassi E, Pervanidou P, Kaltsas G, Metabolic syndrome: definitions and controversies[J]. BMC Med, 2011, 9(48): 48

[2] Scuteri A, Najjar SS, Morrell CH, , and the Cardiovascular Health Study. The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study[J]. Diabetes Care, 2005, 28(4): 882–887

[3] Wannamethee SG, Shaper AG, Lennon L, Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus[J]. Arch Intern Med, 2005, 165(22): 2644–2650

[4] Ford ES. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study[J]. Atherosclerosis, 2004, 173(2): 309–314

[5] al-Adsani H, Hoffer LJ, Silva JE. Resting energy expenditure is sensitive to small dose changes in patients on chronic thyroid hormone replacement[J]. J Clin Endocrinol Metab, 1997, 82(4): 1118–1125

[6] Krotkiewski M. Thyroid hormones and treatment of obesity[J]. Int J Obes Relat Metab Disord, 2000, 24(Suppl 2): S116–S119

[7] Park SB, Choi HC, Joo NS. The relation of thyroid function to components of the metabolic syndrome in Korean men and women[J]. J Korean Med Sci, 2011, 26(4): 540–545

[8] Roos A, Bakker SJ, Links TP, Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects[J]. J Clin Endocrinol Metab, 2007, 92(2): 491–496

[9] Fommei E, Iervasi G. The role of thyroid hormone in blood pressure homeostasis: evidence from short-term hypothyroidism in humans[J]. J Clin Endocrinol Metab, 2002, 87(5): 1996–2000

[10] Hak AE, Pols HAP, Visser TJ, Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study[J]. Ann Intern Med, 2000, 132(4): 270–278

[11] Park HT, Cho GJ, Ahn KH, Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women[J]. Maturitas, 2009, 62(3): 301–305

[12] Oh JY, Sung YA, Lee HJ. Elevated thyroid stimulating hormone levels are associated with metabolic syndrome in euthyroid young women[J]. Korean J Intern Med, 2013, 28(2): 180–186

[13] Fatourechi V, Klee GG, Grebe SK, Effects of reducing the upper limit of normal TSH values[J]. JAMA, 2003, 290(24): 3195–3196

[14] Kratzsch J, Fiedler GM, Leichtle A, New reference intervals for thyrotropin and thyroid hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid[J]. Clin Chem, 2005, 51(8): 1480–1486

[15] Ning G, and the Reaction Study Group. Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study[J]. J Diabetes, 2012, 4(2): 172–173

[16] Bi Y, Lu J, Wang W, Cohort profile: risk evaluation of cancers in Chinese diabetic individuals: a longitudinal (REACTION) study[J]. J Diabetes, 2014, 6(2): 147–157

[17] Alberti KG, Zimmet P, Shaw J, and the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome—a new worldwide definition[J]. Lancet, 2005, 366(9491): 1059–1062

[18] Dekelbab BH, Abou Ouf HA, Jain I. Prevalence of elevated thyroid-stimulating hormone levels in obese children and adolescents[J]. Endocr Pract, 2010, 16(2): 187–190

[19] Nyrnes A, Jorde R, Sundsfjord J. Serum TSH is positively associated with BMI[J]. Int J Obes (Lond), 2006, 30(1): 100–105

[20] Rotondi M, Leporati P, La Manna A, Raised serum TSH levels in patients with morbid obesity: is it enough to diagnose subclinical hypothyroidism[J]? Eur J Endocrinol, 2009, 160(3): 403–408

[21] Sestoft L. Metabolic aspects of the calorigenic effect of thyroid hormone in mammals[J]. Clin Endocrinol (Oxf), 1980, 13(5): 489–506

[22] Ruiz-Tovar J, Boix E, Galindo I, Evolution of subclinical hypothyroidism and its relation with glucose and triglycerides levels in morbidly obese patients after undergoing sleeve gastrectomy as bariatric procedure[J]. Obes Surg, 2014, 24(5): 791–795

[23] Biondi B. Thyroid and obesity: an intriguing relationship[J]. J Clin Endocrinol Metab, 2010, 95(8): 3614–3617

[24] Iacobellis G, Ribaudo MC, Zappaterreno A, Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women[J]. Clin Endocrinol (Oxf), 2005, 62(4): 487–491

[25] Mantzoros CS, Ozata M, Negrao AB, Synchronicity of frequently sampled thyrotropin (TSH) and leptin concentrations in healthy adults and leptin-deficient subjects: evidence for possible partial TSH regulation by leptin in humans[J]. J Clin Endocrinol Metab, 2001, 86(7): 3284–3291

[26] Winter WE, Signorino MR. Review: molecular thyroidology[J]. Ann Clin Lab Sci, 2001, 31(3): 221–244

[27] Feldt-Rasmussen U. Thyroid and leptin[J]. Thyroid, 2007, 17(5): 413–419

[28] Menendez C, Baldelli R, Camiña JP, TSH stimulates leptin secretion by a direct effect on adipocytes[J]. J Endocrinol, 2003, 176(1): 7–12

[29] Ortiga-Carvalho TM, Oliveira KJ, Soares BA, The role of leptin in the regulation of TSH secretion in the fed state: in vivo and in vitro studies[J]. J Endocrinol, 2002, 174(1): 121–125

[30] Seoane LM, Carro E, Tovar S, Regulation of in vivo TSH secretion by leptin[J]. Regul Pept, 2000, 92(1-3): 25–29

[31] Bakker SJL, ter Maaten JC, Popp-Snijders C, The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects[J]. J Clin Endocrinol Metab, 2001, 86(3): 1206–1211

[32] Duntas LH. Thyroid disease and lipids[J]. Thyroid, 2002, 12(4): 287–293

[33] Choi JW, Choi HS. The regulatory effects of thyroid hormone on the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase[J]. Endocr Res, 2000, 26(1): 1–21

[34] Lam KS, Chan MK, Yeung RT. High-density lipoprotein cholesterol, hepatic lipase and lipoprotein lipase activities in thyroid dysfunction—effects of treatment[J]. Q J Med, 1986, 59(229): 513–521

[35] Brenta G, Berg G, Arias P, Lipoprotein alterations, hepatic lipase activity, and insulin sensitivity in subclinical hypothyroidism: response to L-T(4) treatment[J]. Thyroid, 2007, 17(5): 453–460

[36] Zhou X, Han Y, Liu J, Decreased protein and gene expression of hepatic cholesterol 7a-hydroxylase associated with dilated endoplasmic reticulum in chronic hypothyroid rats[J]. Pathol Int, 2009, 59(10): 729–734

[37] Moon JH, Kim HJ, Kim HM, Decreased expression of hepatic low-density lipoprotein receptor-related protein 1 in hypothyroidism: a novel mechanism of atherogenic dyslipidemia in hypothyroidism[J]. Thyroid, 2013, 23(9): 1057–1065

[38] Duan Y, Peng W, Wang X, Community-based study of the association of subclinical thyroid dysfunction with blood pressure[J]. Endocrine, 2009, 35(2): 136–142

[39] Walsh JP, Bremner AP, Bulsara MK, Subclinical thyroid dysfunction and blood pressure: a community-based study[J]. Clin Endocrinol (Oxf), 2006, 65(4): 486–491

[40] Ali SB, Belfki-Benali H, Aounallah-Skhiri H, Menopause and metabolic syndrome in tunisian women[J]. Biomed Res Int, 2014:1–7.

[41] Goyal S, Baruah M, Devi R, Study on relation of metabolic syndrome with menopause[J]. Indian J Clin Biochem, 2013, 28(1): 55–60

Acknowledgements

This study was supported by the grants from the Chinese Society of Endocrinology and National Clinical Research Center for Metabolic Diseases (81170726).

RIGHTS & PERMISSIONS

2016 2016 by the Journal of Biomedical Research. All rights reserved.